Harbour Investments’s Bionano Genomics BNGO Stock Holding History

Harbour Investments’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-7	Closed	-$32K	–	3771
2021 Q1	$32K	Buy	+7	New	+$39.5K	﹤0.01%	1927

Other funds holding BNGO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Bank Julius Baer & Co Zurich, Switzerland $33.2B AUM 25.01% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Harbour Investments's BNGO Position: Q2 2021 in Review

Harbour Investments sold out of Bionano Genomics (BNGO) in Q2 2021, closing a stake of 7 shares — an estimated $32K sold.

Harbour Investments first reported a position in BNGO in Q1 2021 and held it in 1 quarter. The position peaked at $32K in Q1 2021. 152 funds tracked by Wall St. Rank hold BNGO as of Q2 2021.

Harbour Investments reported no remaining Bionano Genomics position as of Q2 2021 after selling out during the quarter.
Harbour Investments sold 7 Bionano Genomics shares in Q2 2021, an estimated $32K.
Harbour Investments first reported a position in Bionano Genomics in Q1 2021 and held it in 1 quarter.
Harbour Investments's Bionano Genomics position peaked at $32K in Q1 2021.
152 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2021.

Based on Harbour Investments's 13F filing for Q2 2021, filed 16 Aug 2021.